Nitroglycerin
(Nitrostat, Nitrogard, Nitrolingual, Nitro-Bid, Nitrol, Nitro-Dur, Transderm-Nitro)
Category:
Description:
Indications:
-
Acute
angina, angina prophylaxis, perioperative hypertension, CHF associated
with MI
-
Unresponsive
angina pectoris
Contraindications:
-
Severe
anemia, closed-angle glaucoma, postural hypotension, early MI, head
trauma
-
Cerebral
hemorrhage, hypotension, uncorrected hypovolemia, inadequate cerebral
circulation, increased intracrainial pressure, constrictive
pericarditis, pericardial tamponade (IV)
Precautions:
-
Pregnancy
category C; may use SL for angina
-
Early
days of MI, hypertrophic cardiomyopathy, severe hepatic/renal disease
-
Children,
glaucoma, abrupt withdrawal, continuous delivery
Adverse
Reactions (Side Effects):
-
CNS:
agitation, anxiety, apprehension, confusion, dizziness,
dyscoordination, headache, hypoesthesia, hypokinesia, insomnia,
nervousness, nightmares, vertigo, restlessness
-
CV:
atrial fibrillation, collapse, crescendo angina, dysrhythmias,
palpitations, postural hypotension, PVC’s, rebound hypertension,
retrosternal discomfort, syncope, tachycardia
-
GI:
abdominal pain, diarrhea, dyspepsia, fecal incontinence, nausea,
tenesmus
-
GU:
dysuria, impotence, urinary frequency
-
HEME:
hemolytic anemia, methemoglobinemia
-
SKIN:
allergic reactions (ointment), contact dermatitis (transdermal),
crusty skin lesions, cutaneous vasodilation with flushing, exfloiative
dermatitis, rash, sweating
|
Dosage:
Administered
orally (spray, capsule, SL tablet, EC tablet, buccal tablet), topically (transdermal,
ointment), and intravenously
-
Adult:
-
BUCCAL
1mg every 3-5 hours while awake initially, titrate dosage upward
if angina occurs with tablet in place
-
PO
2.5-9mg 2-4 times daily, up to 26mg 4 times daily;
-
IV
5 mcg/min via continuous infusion, increase by 5 mcg/min every 3-5
minutes to 20 mcg/min; if no response, increase by 10 mcg/min
every 3-5 minutes up to 200 mcg min;
-
TOP
1-2 inches every 8 hours, up to 4-5 inches every 4 hours
-
TRANSDERMAL
0.2-0.4 mg/hr initially, titrate to 0.4-0.8 mg/hr; apply new patch
daily; tolerance is minimized by removing patch for 10-12 hours
daily
-
SL
0.2-0.6mg every 5 minutes for a max of 3 doses in 15 minutes; may
also use prophylactically 5-10 minutes prior to activities that
provoke angina attack
-
Child:
Special
Considerations:
|
Home
· Military Medicine
· Sick Call · Basic Exams
· Medical Procedures
· Lab and X-ray · The Pharmacy
· The Library · Equipment
· Patient Transport
· Medical Force
Protection · Operational Safety · Operational
Settings · Special
Operations · Humanitarian
Missions · Instructions/Orders · Other Agencies · Video Gallery
· Forms · Web Links · Acknowledgements
· Help · Feedback Approved for public release;
Distribution is unlimited. The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.
Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.
Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations
Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
*This web version is provided by The Brookside Associates, LLC. It contains
original contents from the official US Navy NAVMED P-5139, but has been
reformatted for web access and includes advertising and links that were not
present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the
Department of the Navy or the Department of Defense. The presence of any
advertising on these pages does not constitute an endorsement of that product or
service by either the US Department of Defense or the Brookside Associates. The
Brookside Associates is a private organization, not affiliated with the United
States Department of Defense.
© 2015, Brookside Associates, LLC. All rights reserved
Other Brookside Products
|
|